What is the accuracy of the clinical diagnosis of multiple system atrophy?: A clinicopathologic study

Archives of Neurology

Volumn 54, Issue 8, 1997, Pages 937-944

  Litvan, Irene ^a   Goetz, Chris G ^c   Jankovic, Joseph ^d   Wenning, Gregory K ^e   Booth, Valencia ^a   Bartko, John J ^b   McKee, Ann ^h   Jellinger, Kurt ⁱ   Lai, Eugene C ^d   Brandel, Jean Philippe ^j   Verny, Marc ^j   Ray Chaudhuri, K ^f   Pearce, Ron K B ^e,g   Agid, Yves ^j  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^c RUSH MEDICAL COLLEGE   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

^f KING'S COLLEGE LONDON   (United Kingdom)

^g Institute of Neurology   (United Kingdom)

^h MASSACHUSETTS GENERAL HOSPITAL   (United States)

ⁱ LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

^j PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; NEUROPATHOLOGY; OBSERVER VARIATION; PARKINSON DISEASE; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; RELIABILITY; SHY DRAGER SYNDROME;

EID: 0030841071     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.1997.00550200007003     Document Type: Article

References (57)

1. Gilman S, Quinn NP. The relationship of multiple system atrophy to sporadic olivopontocerebellar atrophy and other forms of idiopathic late-onset cerebellar atrophy. Neurology. 1996;46:1197-1199.
2. Consensus Committee of the American Autonomic Society and the American Academy of Neurology. Consensus statement on the definition of orthostatic hypotension, pure autonomic failure, and multiple system atrophy. Neurology. 1996; 46:1470.
3. Horoupian DS. Oligodendroglial and neuronal cytoplasmic inclusions in multisystem atrophy. Prog Brain Res. 1992;94:423-428.
4. Papp MI, Kahn JE, Lantos PL. Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome). J Neurol Sci. 1989;94:79-100.
5. Quinn N. Multiple system atrophy - the nature of the beast. J Neurol Neurosurg Psychiatry. 1989;52(suppl):78-89.
6. Shy GM, Drager GA. A neurologic syndrome associated with orthostatic hypotension. Arch Neurol. 1960;2:511-527.
7. Adams RA, Van Bogaert L, Van der Eecken H. Striato-nigral degeneration. J Neuropathol Exp Neurol. 1964;23:584-608.
8. Dejerine J, Thomas AA. L'atrophie olivo-ponto-cerebelleuse. Nouv Iconogr Salpetriere. 1900;13:330-370.
9. Quinn NP, Marsden CD. The motor disorder of multiple system atrophy. J Neurol Neurosurg Psychiatry. 1993;56:1239-1242.
10. Wenning GK, Ben Shlomo Y, Magalhaes M, Daniel SE, Quinn NP. Clinical features and natural history of multiple system atrophy: an analysis of 100 cases. Brain. 1994;117:835-845.
11. Quinn N. Multiple system atrophy. In: Marsden C, Fahn S, eds. Movement Disorders 3. Newton, Mass: Butterworth-Heinemann; 1994:262-281.
12. Schulz JB, Klockgether T, Petersen D, et al. Multiple system atrophy: natural history, MRI morphology, and dopamine receptor imaging with 123IBZM-SPECT. J Neurol Neurosurg Psychiatry. 1994;57:1047-1056.
13. Wenning GK, Tison F, Ben-Shlomo Y, Daniel SE, Quinn NP. Multiple system atrophy: a review of 203 pathologically proven cases. Mov Disord. 1997;12:133-147.
14. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry. 1992;55:181-184.
15. McKeith IG, Galasko D, Kosaka K, et al. Consensus guidelines for the clinical and pathological diagnosis of dementia with Lewy bodies (DLB): report of the Consortium on DLB International Workshop. Neurology. 1996;47:1113-1124.
16. Papp MI, Lantos PL. Accumulation of tubular structures in oligodendroglial and neuronal cells as the basic alteration in multiple system atrophy. J Neurol Sci. 1992;107:172-182.
17. Papp MI, Lantos PL. The distribution of oligodendroglial inclusions in multiple system atrophy and its relevance to clinical symptomatology. Brain. 1994;117: 235-243.
18. Lantos PL. Neuropathological diagnostic criteria of multiple system atrophy: a review. In: Cruz-Sanchez FF, Ravid R, Cuzner ML, eds. Neuropathological Diagnostic Criteria for Brain Banking. Amsterdam, the Netherlands: IOS Press; 1995: 116-121.
19. Gilman S, Sima AF, Junck L, et al. Spinocerebellar ataxia type 1 with multiple system degeneration and glial cytoplasmic inclusion. Ann Neurol. 1996;39:241-255.
20. Daniel SE, Geddes JF, Revesz T. Glial cytoplasmic inclusions are not exclusive to multiple system atrophy. J Neurol Neurosurg Psychiatry. 1995;58:262.
21. Tison F, Wenning GK, Daniel SE, Quinn NP. Multiple system atrophy with Lewy bodies. Rev Neurol (Paris). 1995;151:398-403.
22. Wenning G, Quinn N. Are Lewy bodies non-specific epiphenomena of nigral damage? Mov Disord. 1994;9:378-379.
23. Litvan I, Agid Y, Jankovic J, et al. Accuracy of clinical criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome). Neurology. 1996;46:922-930.
24. Litvan I, Agid Y, Goetz C, et al. Accuracy of the clinical diagnosis of corticobasal degeneration: a clinicopathological study. Neurology. 1997;48:119-125.
25. Litvan I, Agid Y, Sastri N, et al. What are the obstacles for an accurate clinical diagnosis of Pick's disease? a clinicopathologic study. Neurology. In press.
26. Hauw JJ, Daniel SE, Dickson D, et al. Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear patsy). Neurology. 1994;44:2015-2019.
27. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159-174.
28. Fleiss JL. Statistical Methods for Rates and Proportions. New York, NY: John Wiley & Sons Inc; 1981.
29. Galen S, Gambino SR. Beyond Normality: the Predictive Value and Efficiency of Medical Diagnoses. New York, NY: John Wiley & Sons Inc; 1975.
30. SAS Institute Inc. SAS Procedures Guide, Version 6. Cary, NC: SAS Institute Inc; 1990.
31. SAS Institute Inc. JMP Statistics and Graphics Guide, Version 3. Cary, NC: SAS Institute Inc; 1994.
32. Efron B. The Jackknife, the Bootstrap and Other Resampling Plans. Philadelphia, Pa: SIAM; 1982.
33. Gouider-Khouja N, Vidailhet M, Bonnet AM, Pichon J, Agid Y. 'Pure' striatonigral degeneration and Parkinson's disease: a comparative clinical study. Mov Disord. 1995;10:288-294.
34. Meco G, Gasparini M, Doricchi F. Attentional functions in multiple system atrophy and Parkinson's disease. J Neurol Neurosurg Psychiatry. 1996;60:393-398.
35. Pillon B, Gouider-Khouja N, Deweer B, et al. Neuropsychological pattern of striatonigral degeneration: comparison with Parkinson's disease and progressive supranuclear palsy. J Neurol Neurosurg Psychiatry. 1995;58:174-179.
36. Robbins TW, James M, Lange KW, Owen AM, Quinn NP, Marsden CD. Cognitive performance in multiple system atrophy. Brain. 1992;115:271-291.
37. Robbins TW, James M, Owen AM, et al. Cognitive deficits in progressive supranuclear palsy, Parkinson's disease, and multiple system atrophy in tests sensitive to frontal lobe dysfunction. J Neurol Neurosurg Psychiatry. 1994;57:79-88.
38. Wenning GK, Ben-Shlomo Y, Magalhaes M, Daniel SE, Quinn NP. Clinicopathological study of 35 cases of multiple system atrophy. J Neurol Neurosurg Psychiatry. 1995;58:160-166.
39. Mayeux R, Marder K, Cote LJ, et al. The frequency of idiopathic Parkinson's disease by age, ethnic group, and sex in northern Manhattan, 1988-1993. Am J Epidemiol. 1995;142:820-827.
40. Morgante L, Rocca WA, Di Rosa AE, et al. Prevalence of Parkinson's disease and other types of parkinsonism: a door-to-door survey in three Sicilian municipalities: The Sicilian Neuro-Epidemiologic Study (SNES) Group. Neurology. 1992; 42:1901-1907.
41. Stacy M, Jankovic J. Differential diagnosis of Parkinson's disease and the parkinsonism plus syndromes. Neurol Clin. 1992;10:341-359.
42. Colosimo C, Albanese A, Hughes AJ, de Bruin VM, Lees AJ. Some specific clinical features differentiate multiple system atrophy (striatonigral variety) from Parkinson's disease. Arch Neurol. 1995;52:294-298.
43. Gubskii LV. Diagnosis and treatment of Shy-Drager syndrome. Sov Med. 1989; 6:115-117.
44. Rajput AH, Rozdilsky B, Rajput A. Accuracy of clinical diagnosis in parkinsonism - a prospective study. Can J Neurol Sci. 1991;18:275-278.
45. Jellinger KA. Neurodegenerative disorders with extrapyramidal features - a neuropathological overview. J Neural Transm Suppl. 1995;46:33-57.
46. Hoehn MM, Yahr MD. Parkinsonism: onset, progression, and mortality. Neurology. 1967;17:427-442.
47. Litvan I, Agid Y, Calne D, et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology. 1996;47:1-9.
48. Albanese A, Colosimo C, Bentivoglio AR, et al. Multiple system atrophy presenting as parkinsonism: clinical features and diagnostic criteria. J Neurol Neurosurg Psychiatry. 1995;59:144-151.
49. Eardley I, Quinn NP, Fowler CJ, et al. The value of urethral sphincter electromyography in the differential diagnosis of parkinsonism. Br J Urol. 1989;64:360-362.
50. Brooks DJ, Ibanez V, Sawle GV, et al. Differing patterns of striatal 18F-dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy. Ann Neurol. 1990;28:547-555.
51. Testa D, Savoiardo M, Fetoni V, et al. Multiple system atrophy: clinical and MR observations on 42 cases. Ital J Neuroi Sci. 1993;14:211-216.
52. Gilman S, Koeppe RA, Junck L, Kluin KJ, Lohman M, St Laurent RT. Patterns of cerebral glucose metabolism detected with positron emission tomography differ in multiple system atrophy and olivopontocerebellar atrophy. Ann Neurol. 1994; 36:166-175.
53. Gilman S, St Laurent RT, Koeppe RA, Junck L, Kluin KJ, Lohman M. A comparison of cerebral blood flow and glucose metabolism in olivopontocerebellar atrophy using PET. Neurology. 1995;45:1345-1352.
54. Burn DJ, Rinne JO, Quinn NP, Lees AJ, Marsden CD, Brooks DJ. Striatal opioid receptor binding in Parkinson's disease, striatonigral degeneration and Steele-Richardson-Olszewski syndrome: a [11C]diprenorphine PET study. Brain. 1995; 118:951-958.
55. Davie CA, Wenning GK, Barker GJ, et al. Differentiation of multiple system atrophy from idiopathic Parkinson's disease using proton magnetic resonance spectroscopy. Ann Neurol. 1995;37:204-210.
56. Pramstaller PP, Wenning GK, Smith SJ, Beck RO, Quinn NP, Fowler CJ. Nerve conduction studies, skeletal muscle EMG, and sphincter EMG in multiple system atrophy. J Neurol Neurosurg Psychiatry. 1995;58:618-621.
57. Kluin KJ, Gilman S, Lohman M, Junck L. Characteristics of the dysarthria of multiple system atrophy. Arch Neurol. 1996;53:545-548.